Clinical Trials Browser

Breast Neoplasms, Neoplasm, Residual, Breast Neoplasms, Male

NCT03705806 2026-03-04

Palliative Thoracic ImmunoRT

Active not recruiting

12 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05863052 2026-02-10

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

Active not recruiting

72 enrolled

DermatologicGastrointestinalGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis

NCT03387553 2026-02-09

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

Phase EARLY_PHASE1 Active not recruiting

31 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT03614949 2025-12-19

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Phase 2 Active not recruiting

21 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06146920 2025-11-18

Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation

Phase NA Active not recruiting

39 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma

NCT04926948 2025-10-22

Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma

Phase 1 Active not recruiting

20 enrolled

Thoracic

Pleural Mesothelial Neoplasm

NCT03721341 2025-09-18

SABR-COMET 10

Phase 3 Active not recruiting

204 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT02276443 2025-08-01

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

Phase NA Active not recruiting

798 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT04447651 2025-07-14

PRISMM

Active not recruiting

6 enrolled

Tumor-Agnostic

Neoplasm Metastasis

NCT06960889 2025-05-07

A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients

Active not recruiting

500 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT04612309 2025-03-13

C-MSI

Active not recruiting

100 enrolled

Gastrointestinal

Colorectal Neoplasms

NCT06700421 2024-11-22

Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

Phase 2 Active not recruiting

32 enrolled

Radiation Pneumonitis

NCT06518018 2024-07-24

HIBIC-NSCLC

Active not recruiting

80 enrolled

Thoracic

Barakat syndrome, Carcinoma, Non-Small-Cell Lung

Clinical Trials

Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer

Palliative Thoracic ImmunoRT

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer

SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

Use of Serial Plasma NGS as a New Efficacy Metric to Guide Immunotherapy Treatment Discontinuation

Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma

SABR-COMET 10

Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative

PRISMM

A Retrospective Clinical Study Exploring Prognostic Factors in Esophageal Cancer Patients

C-MSI

Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

HIBIC-NSCLC